You are here: Industry Insights > china

News List

WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang en-cphi.cn
November 01, 2018
The new Biologics Center will be one of the largest in northern China
Hepatitis B Drug Market to Reach RMB 20 Billion in China by 2020 Daling
November 01, 2018
A Brief Description of Anti-Hepatitis B Drugs
CPhI Worldwide records 44,500 attendees from 164 countries expressbpd
October 25, 2018
CPhI Worldwide pharma survey shows improving outlook for pharma economies globally, with China and India showing the fastest improvement.
CASI Pharmaceuticals Acquires Laurus Lab's HBV Drug contractpharma
October 24, 2018
Expands pipeline and mission to commercialize U.S. FDA approved drugs in China
Overview of EU and U.S. PV Regulations and PV Regulation Trend after China Joined ICH--China zhulikou431
October 12, 2018
In China, people often equate PV with adverse drug reaction (ADR) monitoring, but in fact, PV is not simply ADR monitoring; it is a gradual outward expanding process with ADR monitoring at its core.
Govt aims to raise API production to cut Chinese dependence expressbpd
October 11, 2018
The government is working on a road map to increase production of bulk drugs in the country with a view to reduce import
Jinxin Fertility announces completion of major financing round biospectrum
October 11, 2018
With its outstanding competitive edges, Jinxin Fertility has become a rare privately-owned assisted reproductive institution in China that is able to compete with the best local public hospitals and even take a leading position in the field.
CASI Pharmaceuticals appoints new president for China Operations biospectrum
October 10, 2018
Zhang possesses over 20 years of executive experience in commercial operations, regulatory affairs, sales and marketing, and business development within the healthcare and biopharmaceutical industries in the U.S., Asia Pacificand China
Changchun High, New Technology form $200 M JV biospectrumasia
September 29, 2018
Changchun will fund the JV with $100 million while Alvotech will contribute $10 million plus six drug licenses valued at $90 million.
DiaMedica, Ahon Pharma sign license agreement for stroke treatment biospectrumasia
September 29, 2018
Under the terms of the license agreement, DiaMedica is entitled to receive an upfront payment of $5 million, consisting of $500,000 on signing...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page